Insider · CIK 0001875786

Auster Martin

Reports to the SEC for 1 company · ENCINITAS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001875786

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-04-02	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,405 sh	$5.40	−$7,591.918	24,303
2024-03-28	VTYXVentyx Biosciences, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+4,531 sh	—	—	25,708
2024-03-28	VTYXVentyx Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−4,531 sh	—	—	13,594
2024-01-02	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+125K sh	—	—	125,000
2023-12-18	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+181K sh	—	—	181,250
2023-09-05	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−18.3K sh	$32.26	−$591K	29,322
2023-09-05	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−8,142 sh	$33.41	−$272K	21,180
2023-09-05	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−3 sh	$33.98	−$101.939	21,177
2023-07-25	VTYXVentyx Biosciences, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+28K sh	$3.45	+$96.6K	75,649
2023-07-25	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−28K sh	$35.54	−$995K	47,649
2023-07-25	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−28K sh	—	—	219,184
2023-06-06	VTYXVentyx Biosciences, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+28K sh	$3.45	+$96.6K	75,649
2023-06-06	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−24.2K sh	$34.59	−$839K	51,403
2023-06-06	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−3,754 sh	$34.95	−$131K	47,649
2023-06-06	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−28K sh	—	—	247,184
2023-04-25	VTYXVentyx Biosciences, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+28K sh	$3.45	+$96.6K	75,649
2023-04-25	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−18.7K sh	$37.55	−$704K	56,901
2023-04-25	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−4,262 sh	$38.76	−$165K	52,639
2023-04-25	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−4,990 sh	$39.23	−$196K	47,649
2023-04-25	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−28K sh	—	—	275,184
2023-04-17	VTYXVentyx Biosciences, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+7,000 sh	$3.45	+$24.2K	54,649
2023-04-17	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−7,000 sh	$33.00	−$231K	47,649
2023-04-17	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−7,000 sh	—	—	303,184
2023-04-04	VTYXVentyx Biosciences, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+21K sh	$3.45	+$72.5K	68,649
2023-04-04	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−9,577 sh	$30.24	−$290K	59,072
2023-04-04	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−9,535 sh	$31.07	−$296K	49,537
2023-04-04	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,888 sh	$31.86	−$60.2K	47,649
2023-04-04	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−21K sh	—	—	310,184
2023-01-17	VTYXVentyx Biosciences, Inc. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+109K sh	—	—	108,750
2023-01-17	VTYXVentyx Biosciences, Inc. · Restricted Stock UnitsA Award	CHIEF FINANCIAL OFFICER	AAward	+18.1K sh	—	—	18,125
2022-12-02	VTYXVentyx Biosciences, Inc.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+50K sh	$3.45	+$173K	145,296
2022-12-02	VTYXVentyx Biosciences, Inc.S Sale	CHIEF FINANCIAL OFFICER	SSale	−97.6K sh	$29.01	−$2.83M	47,649
2022-12-02	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−50K sh	—	—	331,184
2022-02-04	VTYXVentyx Biosciences, Inc. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+145K sh	—	—	145,000

Recent filings

Accepted (ET)
Apr 34
Auster Martin0001415889-24-010177
SEC(opens sec.gov)
Mar 294
Auster Martin0001415889-24-009456
SEC(opens sec.gov)
Jan 34
Auster Martin0001209191-24-000537
SEC(opens sec.gov)
Dec 194
Auster Martin0001209191-23-059222
SEC(opens sec.gov)
Sep 74
Auster Martin0001209191-23-048632
SEC(opens sec.gov)
Jul 264
Auster Martin0001209191-23-043460
SEC(opens sec.gov)
Jun 74
Auster Martin0001209191-23-035224
SEC(opens sec.gov)
Apr 274
Auster Martin0001209191-23-025876
SEC(opens sec.gov)

Companies

Ventyx Biosciences, Inc.CHIEF FINANCIAL OFFICERVTYX

Address

C/O VENTYX BIOSCIENCES, INC. 662 ENCINITAS BLVD, SUITE 250

ENCINITAS, CA, 92024